Immunohistochemical algorithm alone is not enough for predicting the outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP

Gene expression profiling (GEP), which can divide DLBCL into three groups, is impractical to perform routinely. Although algorithms based on immunohistochemistry (IHC) have been proposed as a surrogate for GEP analysis, the power of them has diminished since rituximab added to the chemotherapy. We a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Clin Exp Pathol
Huvudupphovsmän: Lu, Ting-Xun, Gong, Qi-Xing, Wang, Li, Fan, Lei, Zhang, Xiao-Yan, Chen, Yao-Yu, Wang, Zhen, Xu, Wei, Zhang, Zhi-Hong, Li, Jian-Yong
Materialtyp: Artigo
Språk:Inglês
Publicerad: e-Century Publishing Corporation 2015
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4348926/
https://ncbi.nlm.nih.gov/pubmed/25755714
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk